Image For Activity Cover
BSSO/SSO Joint Virtual Tumor Board - Multidisciplinary Management of Pancreatic Ductal Adenocarcinoma
Activity Overview

The participants will be able to:

  • Address patients with resectable and borderline resectable PDAC in the light of new evidence
  • Effectively stage and define criteria for upfront surgery and for neoadjuvant chemo
  • Discuss the role of radiation therapy on neoadjuvant and adjuvant setting
  • Explore nuances of patient selection based on molecular profile. Does it matter for resectable and borderline resectable patients?


Héber Salvador, MD - AC Camargo Cancer Center, São Paulo, Brazil
Douglas S. Tyler, MD, FSSO - University of Texas Medical Branch, Texas, USA

Surgical Oncologists:
1) Marciano Anghinoni (BSSO) - Hospital São Vicente, Curitiba – PR, Brazil
2) Felipe Coimbra (BSSO) – AC Camargo Cancer Center, São Paulo – SP, Brazil
3) Peter Allen, MD, FSSO (SSO) – Duke University, USA
4) Cristina R. Ferrone, MD, MS (SSO) - Massachusetts General Hospital, USA

Medical Oncologist:
Paulo Hoff, MD, PhD (BSMO) – Rede D’Or, São Paulo – SP, Brazil

Radiation Oncologist:
Arthur Rosa, MD, PhD (BSRO) – Oncoclinicas, Salvador – BA, Brazil 
Availability: On-Demand
Cost: FREE
Credit Offered:
No Credit Offered
Powered By